Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
about
Angiotensin receptor blockers for heart failureAliskiren: the first renin inhibitor for clinical treatmentHemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension.Changes in the renin angiotensin system during the development of colorectal cancer liver metastases.Combination therapy in hypertension: An update.Local delivery of a direct renin inhibitor into the kidney ameliorates progression of experimental glomerulonephritis.Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interactionRole of aliskiren in blood pressure control and renoprotectionEffects of combination of aliskiren and pentoxyfylline on renal function in the rat remnant kidney model of chronic renal failure.Effect of aliskiren on cardiovascular outcomes in patients with prehypertension: a meta-analysis of randomized controlled trials.Inhibition of the Prostaglandin Transporter PGT Lowers Blood Pressure in Hypertensive Rats and MiceAngiotensin converting enzyme 2, Angiotensin-(1-7), and receptor MAS axis in the kidney.Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjectsNitric oxide inhibits the expression of AT1 receptors in neurons.Polymorphism in angiotensin II receptor genes and hypertension.Overview of resistant hypertension: A glimpse of the cardiologist's current standpoint.Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats.Inhibition of renin activity slows down the progression of HIV-associated nephropathyRAS inhibition in hypertension.Management strategies for patients with hypertension and diabetes: why combination therapy is critical.Role of the JAK/STAT signaling pathway in diabetic nephropathy.Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidence.Aliskiren: a renin inhibitor offering a new approach for the treatment of hypertension.ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D).Aliskiren: an oral direct renin inhibitor for the treatment of hypertension.New therapeutic agents in diabetic nephropathy.Plasma Renin Activity Predicts the Improvement in Resistant Hypertension after Percutaneous Transluminal Renal Artery Angioplasty.The role of RAS modification for primary and secondary stroke prevention.Application of direct renin inhibition to chronic kidney disease.Hypertension treatment update: focus on direct renin inhibition.The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease.Renin inhibitors and cardiovascular and renal protection: an endless quest?From an ACE polymorphism to genome-wide searches for eQTL.Aliskiren binds to renin and prorenin bound to (pro)renin receptor in vitro.Effects of direct renin inhibition on atherosclerotic biomarkers in patients with stable coronary artery disease and type 2 diabetes mellitus.Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension.Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension.Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes.Renin inhibition with aliskiren.
P2860
Q24199125-EBB11AFD-A65D-4F79-8497-096F695B9271Q28272666-3876FE94-FF8D-448D-AE42-7C104DBD9041Q30415031-FE3F7DE8-4F68-4915-821C-778235111245Q33551485-714E6DE4-FC83-43C7-A5F2-90A3830726F4Q33980931-226DBA26-AB0C-42EE-9E31-3353C81B3C96Q34156850-AC636333-A3C2-4FED-B1CA-DA6D82258E2BQ34231611-C3A01C1A-6948-4DD8-969B-DDA5354AE4EDQ35026735-0BB7DE91-010D-4604-937D-3C31960A56B0Q35222407-547C2546-01AF-4FF1-973B-2007E5D7ED5DQ35408572-E33C68B9-0E7E-44C9-8BBA-0B5F9851B041Q35677376-5D76ABAD-A9F2-4917-BAF8-F088CF181721Q35810568-672C75D2-2692-437D-9439-9ADC0B15C713Q35827907-B6319DEC-E25D-40AA-86D5-86F0BDF808ECQ35900673-957170AD-5FC0-4080-8916-DE95A7962DC1Q36003958-4D12BE8F-C2EE-4C88-A413-B168166AB676Q36285503-7878865B-5F4A-493B-B61C-E33E85F1B3B4Q36296054-19B8A266-4B41-420F-B744-A1CC2224BD8AQ36309378-F2EA96D6-DD07-487B-800D-F46450F51A65Q36362382-DE33354A-CA03-4EB0-A9F4-63E3B5DB8A0DQ36392677-BBB85EF4-DDFC-4A38-94C5-99C9598EDB29Q36417656-9C57C34E-B610-450D-B08D-AE15386DB8E0Q36480076-1AC0772D-5DBC-4401-852A-941DDA2FBB07Q36600306-DA2B8476-2ABD-480D-8DD8-17776D015418Q36929414-FD7DD0C4-7CDB-4C3C-BAE9-E3DC90602F72Q37087865-68F44E09-0189-4D38-9DC0-DD88DCDF76FEQ37377943-6885702F-6A2B-429F-B4F1-C7F32743DEF1Q37559164-45F79556-E9C2-4204-AC18-16F6EE2739DAQ37562732-085A1CF9-FBE5-470E-AF4D-8BAD539D826EQ37566079-9B457C67-FC71-4ACB-AB31-11F45EB976E2Q37758534-874B2487-862F-4C2B-845A-371B9ED93F8CQ37868721-AC7BF507-C36E-4F5E-A5A6-6811E1226ECEQ37938867-4516933B-0686-4BCB-9D30-A3F7FFD272EEQ37990796-A2151DA5-6E33-4198-9193-F51A7E49E2C1Q38071073-796C6048-4710-4095-89BA-871748CA6661Q42954961-239A8270-E7C5-4FC7-85D2-939ADD4D873EQ45195936-AECF8944-5617-4CB9-A71E-3F964C436A95Q45925621-81CD5FAC-A76F-4B54-B369-A6DA45E4AE15Q45925622-DDBAEB2D-5071-4535-ACDC-2E179DDA81FBQ46005128-D5A690C4-2E49-4454-9355-6ABB4738C87FQ46727866-CCA7EC13-15DA-4CF3-9A05-DBD2A328E79F
P2860
Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Combined blockade of the renin ...... I type 1 receptor antagonists.
@ast
Combined blockade of the renin ...... I type 1 receptor antagonists.
@en
type
label
Combined blockade of the renin ...... I type 1 receptor antagonists.
@ast
Combined blockade of the renin ...... I type 1 receptor antagonists.
@en
prefLabel
Combined blockade of the renin ...... I type 1 receptor antagonists.
@ast
Combined blockade of the renin ...... I type 1 receptor antagonists.
@en
P1433
P1476
Combined blockade of the renin ...... I type 1 receptor antagonists.
@en
P2093
Joël Ménard
Michel Azizi
P304
P356
10.1161/01.CIR.0000131449.94713.AD
P407
P577
2004-06-01T00:00:00Z